Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Erol C., Nahit Sendur M. A., Bilgetekin I., Garbioglu D. B., Hamdard J., Akbas S., et al.
Journal of cancer research and therapeutics, vol.18, 2022 (SCI-Expanded) Sustainable Development identifier identifier

Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma

Yalcinkaya B., Tastekin D., Guezelbulut F., Akgoz M., PENÇE S.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, vol.68, no.9, pp.1161-1165, 2022 (SCI-Expanded) identifier identifier identifier

Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study

Karabulut S., Dogan I., Usul Afsar C., Karabulut M., Karaman S., Ferhatoglu F., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.27, no.6, pp.1357-1363, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Dogan I., Tastekin D., Karabulut S., Sakar B.
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.3, 2021 (SCI-Expanded) identifier

Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma

Yalcinkaya B., Guzel Tanoglu E., Tastekin D., Pence S.
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.2, pp.638-643, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier identifier

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

Hacioglu M. B., Kostek O., Karabulut S., Tastekin D., SEZGİN GÖKSU S., Alandag C., et al.
JOURNAL OF BUON, vol.25, no.4, pp.1897-1903, 2020 (SCI-Expanded) identifier identifier identifier

Investigation of JAM-A (rs790056) and LFA-1 (rs8058823) gene variants in Turkish colorectal cancer patients

Caykara B., Alsaadoni H., Pence H. H., Pence S., Aydogan H., Tastekin D.
TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.10, pp.872-876, 2019 (SCI-Expanded) Sustainable Development identifier identifier identifier

ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE

Bademler S., Ucuncu W. Z., Sari M., Yasasever C., Afsar C. U., Tastekin D.
ACTA MEDICA MEDITERRANEA, vol.35, no.1, pp.71-75, 2019 (SCI-Expanded) Sustainable Development identifier identifier

Evaluation of JAM-A (rs790056) and LFA-1 (rs8058823) Variants in Colorectal Cancer

Caykara B., Alsaadoni H., PENÇE H. H., Pence S., Aydogan H., Tastekin D.
ACTA PHYSIOLOGICA, vol.225, pp.25, 2018 (SCI-Expanded) Sustainable Development identifier

Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.

Gurdal N., Fayda M., ALISHEV N., Bakir B., Tastekin D., Aykan F., et al.
Tumori, vol.104, pp.266-272, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

Inal A., Kodaz H., Odabas H., Duran A. O., ŞEKER M. M., Inanc M., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, no.3, pp.578-582, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., Tastekin D., Akyol M., et al.
CLINICAL COLORECTAL CANCER, vol.16, no.3, pp.220-227, 2017 (SCI-Expanded) identifier identifier identifier

Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO)

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., TAŞTEKİN D., Akyol M., et al.
JOURNAL OF BUON, vol.21, no.5, pp.1242-1249, 2016 (SCI-Expanded) identifier

Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.
BIOMEDICINE & PHARMACOTHERAPY, vol.77, pp.27-29, 2016 (SCI-Expanded) identifier identifier identifier

Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.
BIOMEDICINE & PHARMACOTHERAPY, vol.77, pp.86-91, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

The relationship of beck depression inventory with vitamin D levels and visceral fat mass in cancer patients

Tuna S., Mert M., Soyluk O., Okuturlar Y., Kocoglu H., Tastekin D.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.9, no.5, pp.8719-8724, 2016 (SCI-Expanded) Sustainable Development identifier identifier

Clinical significance of serum protease activated receptor1 levels in patients with lung cancer

Erturk K., Tastekin D., Bilgin E., Tas F., Disci R., Duranyildiz D.
European Review for Medical and Pharmacological Sciences, vol.20, no.2, pp.243-249, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer

Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.
TUMOR BIOLOGY, vol.37, no.1, pp.405-412, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.

Tastekın D., Erturk K., Bozbey H. U., Olmuscelık O., Kızıltan H., Tuna S., et al.
Experimental oncology, vol.37, pp.218-22, 2015 (SCI-Expanded) Sustainable Development identifier identifier

Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment

Tezcan Y., Surmeli M., Tastekin D., Koc M.
ARCHIVES OF IRANIAN MEDICINE, vol.18, no.9, pp.606-607, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

Turan N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.
CHINESE JOURNAL OF CANCER RESEARCH, vol.27, no.4, pp.408-416, 2015 (SCI-Expanded) identifier identifier identifier

Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer

Arslan D., Tural D., Koca T., Tastekin D., Cerkesli A. K., Basaran H., et al.
JOURNAL OF BUON, vol.20, no.2, pp.573-579, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.36, no.3, pp.2097-103, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Radioprotectant and Cytotoxic Effects of Spirulina in Relapsed Verrucous Vulvar Cancer: A Case Report

KIZILTAN H. Ş., GÜNEŞ BAYIR A., Taspinar O., Yucesan G., Tastekin D., Sonmez F. C., et al.
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, vol.21, pp.68-72, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.
Biomedicine and Pharmacotherapy, vol.69, pp.237-241, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients

Bal O., Arslan U. Y., Durnali A., Uyetrk U., Demirci A., Tastekin D., et al.
JOURNAL OF BUON, vol.20, no.1, pp.28-34, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation

Tatli A. M., Urakci Z., Kalender M. E., Arslan H., TAŞTEKİN D., Kaplan M. A.
Asian Pacific Journal of Cancer Prevention, vol.16, no.5, pp.2003-2007, 2015 (SCI-Expanded) Sustainable Development identifier identifier

The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity

Tastekin D., Tambas M., KILIC K., Erturk K., ARSLAN D.
INVESTIGATIONAL NEW DRUGS, vol.32, no.6, pp.1295-1300, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients

Tastekin D., Kargin S., KARABULUT M., Yaldiz N., Tambas M., Gurdal N., et al.
TUMOR BIOLOGY, vol.35, no.12, pp.11871-11877, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Clinical significance of serum fibronectin and vitronectin levels in melanoma patients

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.
MELANOMA RESEARCH, vol.24, no.5, pp.475-479, 2014 (SCI-Expanded) identifier identifier identifier

Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

TURAN N., Benekli M., DANE F., Unal O. U., Kara H. V., KOCA D., et al.
Thoracic cancer, vol.5, no.5, pp.398-404, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.
TUMOR BIOLOGY, vol.35, no.9, pp.9303-9309, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.
TUMOR BIOLOGY, vol.35, no.9, pp.8849-8860, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Clinical significance of serum tenascin-c levels in epithelial ovarian cancer

Didem T., Faruk T., Senem K., Derya D., Murat S., Murat G., et al.
TUMOR BIOLOGY, vol.35, no.7, pp.6777-6782, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Clinical significance of serum tenascin-C levels in breast cancer

Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.
TUMOR BIOLOGY, vol.35, no.7, pp.6619-6625, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology

Uyeturk U., Oksuzoglu B., Akman T., Turker I., Sener N., Tastekin D., et al.
MEDICAL ONCOLOGY, vol.31, no.4, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study

KIZILTAN H. Ş., Bayir A. G., Tastekin D., ÇOBAN G., Eris A. H., AYDIN T., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.15, no.20, pp.8591-8594, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Impact of Poster Presentations on Academic Knowledge Transfer from the Oncologist Perspective in Turkey

Arslan D., Koca T., Tastekin D., Basaran H., Bozcuk H.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.15, no.18, pp.7707-7711, 2014 (SCI-Expanded) identifier identifier identifier

Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age <= 35)

Goksu S. S., Tastekin D., Arslan D., Gunduz S., TATLI A. M., Unal D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.15, no.16, pp.6665-6668, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Tas F., Karabulut S., Bilgin E., Sen F., Yildiz I., Tastekin D., et al.
TUMOR BIOLOGY, vol.34, no.6, pp.3529-3536, 2013 (SCI-Expanded) identifier identifier identifier

Rectal cancer in pregnancy: a case report and review of the literature.

Dogan N., Tastekin D., Kerimoglu O., Pekin A., Celik C.
Journal of gastrointestinal cancer, vol.44, pp.354-6, 2013 (SCI-Expanded) Sustainable Development identifier identifier

Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology

Berk V., Kaplan M. A., Tonyali O., Buyukberber S., Balakan O., ÖZKAN M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.12, pp.7367-7369, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.

Hanci V., Kerimoğlu A., Koca K., Başkesen A., Kiliç K., Taştekin D.
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, vol.16, pp.15-21, 2010 (SCI-Expanded) identifier identifier identifier

Correlation between the erythrocyte sedimentation rate and blood nitric oxide levels in rabbits?

Uzun M., Saral S., Atakisi O., Yapar K., Uzlu E., Citil M., et al.
Scandinavian Journal of Laboratory Animal Science, vol.35, no.1, pp.53-56, 2008 (SCI-Expanded) identifier identifier

Investigation of free radical scavenging enzyme activities and lipid peroxidation in liver tissue of zinc deficient rats

Kaya H., Taysi S., Kaya A., Boyuk A., DURSUN H., Islamoglu Y., et al.
Asian Journal of Chemistry, vol.20, no.2, pp.1068-1074, 2008 (SCI-Expanded) identifier identifier

Hypoglycaemic effect of Artemisia herba-alba in experimental hyperglycaemic rats

Taştekin D., ATASEVER M., Adigüzel G., Keleş M., Taştekin A.
Bulletin of the Veterinary Institute in Pulawy, vol.50, no.2, pp.235-238, 2006 (SCI-Expanded) Sustainable Development identifier identifier

Articles Published in Other Journals

Recent Advances in Immunotherapy in the Treatment of Gastrointestinal Tract Cancers

Karabulut S., Topalgokceli M. S., Tastekin D.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, vol.6, no.1, pp.12-15, 2022 (ESCI) Sustainable Development identifier identifier identifier

WHAT'S NEW IN METASTATIC COLON CANCER TREATMENT?

Karabulut S., Karabulut M., Tastekin D.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.84, no.3, pp.425-429, 2021 (ESCI) Sustainable Development identifier identifier

The Association of Pancreatic Cancer and PALB2 Gene Mutations in the Turkish Population

Turkcan G. K., Odemis D., Avsar M., Tuncer S. B., Erciyas S., Erdogan Ö., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.34, no.4, pp.283-290, 2019 (ESCI) identifier identifier

Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients

Kiziltan H. S., TAŞTEKİN D., ERİŞ A. H., Taspinar O., Ismaylova M., MAYADAĞLI A.
BEZMIALEM SCIENCE, vol.4, no.2, pp.51-55, 2016 (ESCI) Sustainable Development identifier

Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.

Tas F., Bilgin E., Tastekın D., Erturk K., Duranyıldız D.
Journal of gastrointestinal cancer, vol.47, pp.182-6, 2016 (Scopus) Sustainable Development identifier identifier

Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS, vol.4, no.5, pp.609-614, 2016 (ESCI) Sustainable Development identifier identifier identifier

Clinical significance of serum laminin levels in patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS, vol.4, no.4, pp.485-488, 2016 (ESCI) Sustainable Development identifier identifier identifier

Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome

Tas F., Bılgın E., Karabulut S., Tastekın D., Duranyıldız D.
MOLECULAR AND CLINICAL ONCOLOGY, vol.4, no.4, pp.655-659, 2016 (ESCI) Sustainable Development identifier identifier

Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients

Tas F., Karabulut S., Tastekin D., Duranyildiz D.
BIOMEDICAL REPORTS, vol.4, no.4, pp.489-492, 2016 (ESCI) Sustainable Development identifier identifier identifier

The Effects of Topical Insulin Application on Wound Healing

Kargin S., Tastekin D., Kilic K., Cezik A., Cakir M., Kucukkartallar T., et al.
EUROPEAN JOURNAL OF GENERAL MEDICINE, vol.12, no.4, pp.302-306, 2015 (ESCI) Sustainable Development identifier identifier

Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, no.4, pp.273-278, 2014 (ESCI) identifier identifier identifier

[The opinions of Turkish physicians about the tasks of tuberculosis central dispensary].

Tanrikulu A., Palanci Y., Eren D., Yilmaz G., Karaca M., Abakay A., et al.
Tuberkuloz ve toraks, vol.57, pp.32-7, 2009 (ESCI) Sustainable Development identifier identifier identifier

Refereed Congress / Symposium Publications in Proceedings

The frequencies and prognostic significance of ABO blood and rhesus (D) groups in HER2-positive gastric cancer

Dogan I., Gurbuz M., Aydin E., Tastekin D., Karabulut S., Utkan G.
ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 July 2020, vol.31 Sustainable Development identifier

Trastuzumab-based treatment of HER2-positive metastatic gastric cancer

Dogan I., Karabulut S., Tastekin D., Paksoy N., Sakar B., Vatansever S.
ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 July 2020, vol.31 Sustainable Development identifier

Does nutritional status affect treatment tolarability, response, and survival in metastatic colorectal cancer patients? Results of prospective multicenter study

Karabulut S., Dogan I., Afsar C. U., Karabulut M., Karaman S., Ferhatoglu F., et al.
Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Costa Rica, 23 - 25 January 2020, vol.38 Sustainable Development identifier

Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi

ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.
3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Turkey, 11 - 15 May 2016, pp.1 Sustainable Development

Rektum kanserinde neoadj. sib-vmat yanıtının difüzyon MR ve serum apoptoz marker düzeyleri ile değerlendirilmesi

GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.
12. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 20 - 24 April 2016, pp.45 Sustainable Development

Nüks meme kanserinde reoperatif sentinel lenf nodu biyopsisi: Aksilla korunabilir mi?

Karanlık H., Özgür İ., Kılıç B., Şanlı Y., Önder S., Taştekin D., et al.
13. Ulusal Meme Hastalıkları Kongresi, 2015, Antalya, Turkey, 21 - 25 October 2015, pp.1 Sustainable Development

The role of adhesion molecules in hepatocellulary carcinoma

Tastekin D., DIKILITAS M., HARPUTLUOGLU H., Erturk K., CELEBI K., Sen F., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 identifier

The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

Turan N., Araz M., Algin E., Unal O. U., Benekli M., Tastekin D., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 identifier

Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 Sustainable Development identifier

Clinical significance of serum epithelial cell adhesion molecule (EPCAM) cud vascular cell adhesion molecule-1 (VCAM-1) levels in lung cancer.

KARABULUT S., Tastekin D., CIFTCI R., Tambas M., DAGOGLU N., Guveil M. E., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 Sustainable Development identifier

Clinical significance of serum caveolin-1 levels in melanoma.

Tastekin D., KARABULUT S., DURANYILDIZ D., Tas F.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 identifier

Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Ciftci R., Karabulut S., Tastekin D., Sen F., Kilic L., Yildiz I., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49 identifier

The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival

Cetin B., TAŞTEKİN D., Aktas B., Guler T., Kaplan M. A., Berk V., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49 identifier

Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Turan N., Dane F., Unal O. U., Benekli M., Kara H. V., Koca D., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 Sustainable Development identifier

Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.

Karabulut S., Kilic L., Ciftci R., Yildiz I., Sen F., Keskin S., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 Sustainable Development identifier

Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.

Ciftci R., Keskin S., Karabulut S., Yildiz I., Kilic L., Sen F., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 identifier